logo-loader

Psyched Wellness makes pre-clinical progress with its Amanita Muscaria-derived wellness product

Published: 14:06 21 Jan 2021 EST

Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) CEO Jeff Stevens tells Proactive the Canadian-based health supplements company specializing in mushroom-derived products is making progress with its Amanita Muscaria mushroom extract.

Stevens says the group has begun pre-clinical studios with Amanita Muscaria, and will look to apply to the FDA as a dietary ingredient and Health Canada for a natural health product when it is completed.

Rush Rare Metals Advances Two Key Projects: Uranium in Wyoming and Niobium...

Rush Rare Metals CEO Peter Smith joined Steve Darling from Proactive to share news about the mineral exploration company's focus on its Boxi Property in Quebec and the Copper Mountain Project in Wyoming. The company recently announced the staking of the Knob claims in Wyoming, comprising 52...

26 minutes ago